共 224 条
[11]
Suganuma I(2004)Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the oral sirolimus to inhibit recurrent in-stent stenosis (OSIRIS) trial Circulation 110 790-5
[12]
Tanaka Y(1994)Rapamycin: a novel immunosuppressive macrolide Med Res Rev 14 1-22
[13]
Sasaki A(2012)mTOR signaling in growth control and disease Cell 149 274-93
[14]
Takahashi Y(2002)Two mTOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control Mol Cell 10 457-68
[15]
Zhu H(2002)mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 163-75
[16]
Yoshimoto T(2002)Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action Cell 110 177-89
[17]
Guo YL(2007)Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 Nat Cell Biol 9 316-23
[18]
Bai R(2007)PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase Mol Cell 25 903-15
[19]
Chen CX(2003)GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol Cell 11 895-904
[20]
Liu DQ(2004)Rictor, a novel binding partner of mTOR, defies a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr Biol 14 1296-302